Cue Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$0.32

+0.00 (+1.27%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +4,820.3% upside

Low Target $10.91

Average Target $15.75

High Target $18.65

Current Price $0.32

Current
$0.32

Target
$15.75

$10.91 $15.75 avg $18.65

Scenario Analysis

Bear Case

$10.91

3,308.3%

Low target

Base Case

$15.75

+4,820.3%

Avg target

Bull Case

$18.65

+5,726.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$19.07

-98.3% from high

52-Week Low

$10.79

+-97.0% from low

Target vs 52W High

$15.75

-17.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%